AI
BRNS

Alphabet Inc’s Barinthus Biotherapeutics BRNS Stock Holding History

Alphabet Inc’s Portfolio BRNS Stock Details BRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,513,644
Closed -$1.89M – 31
2025
Q3 		$1.89M Hold
1,513,644
– – 0.08% 27
2025
Q2 		$1.41M Hold
1,513,644
– – 0.07% 28
2025
Q1 		$1.47M Hold
1,513,644
– – 0.09% 27
2024
Q4 		$1.83M Hold
1,513,644
– – 0.11% 23
2024
Q3 		$1.8M Hold
1,513,644
– – 0.1% 26
2024
Q2 		$2.12M Hold
1,513,644
– – 0.11% 29
2024
Q1 		$3.6M Hold
1,513,644
– – 0.14% 28
2023
Q4 		$5.59M Hold
1,513,644
– – 0.26% 24
2023
Q3 		$4.68M Hold
1,513,644
– – 0.3% 23
2023
Q2 		$3.12M Hold
1,513,644
– – 0.17% 28
2023
Q1 		$3.39M Hold
1,513,644
– – 0.19% 27
2022
Q4 		$3.56M Hold
1,513,644
– – 0.21% 28
2022
Q3 		$4.84M Hold
1,513,644
– – 0.25% 30
2022
Q2 		$6.74M Hold
1,513,644
– – 0.37% 30
2022
Q1 		$7.87M Sell
1,513,644
-190,700
-11% -$1.54M 0.26% 33
2021
Q4 		$18.9M Sell
1,704,344
-100
-0% -$1.26K 0.46% 28
2021
Q3 		$26.8M Hold
1,704,444
– – 0.64% 18
2021
Q2 		$28.6M Buy
+1,704,444
New +$25.2M 0.58% 18

Other funds holding BRNS

HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JHU
Johns Hopkins University Baltimore, Maryland $1.38B AUM 9.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Alphabet Inc's BRNS Position: Q4 2025 in Review

Alphabet Inc sold out of Barinthus Biotherapeutics (BRNS) in Q4 2025, closing a stake of 1,513,644 shares — an estimated $1.89M sold.

Alphabet Inc first reported a position in BRNS in Q2 2021 and held it in 18 quarters. The position peaked at $28.6M in Q2 2021. 13 funds tracked by Wall St. Rank hold BRNS as of Q4 2025.

  • Alphabet Inc reported no remaining Barinthus Biotherapeutics position as of Q4 2025 after selling out during the quarter.
  • Alphabet Inc sold 1,513,644 Barinthus Biotherapeutics shares in Q4 2025, an estimated $1.89M.
  • Alphabet Inc first reported a position in Barinthus Biotherapeutics in Q2 2021 and held it in 18 quarters.
  • Alphabet Inc's Barinthus Biotherapeutics position peaked at $28.6M in Q2 2021.
  • 13 funds tracked by Wall St. Rank held Barinthus Biotherapeutics as of Q4 2025.

Based on Alphabet Inc's 13F filing for Q4 2025, filed 13 Feb 2026.